We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.50 | 0.70% | 1,651.00 | 1,651.00 | 1,652.00 | 1,656.00 | 1,637.00 | 1,650.50 | 4,661,376 | 16:35:08 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.80 | 68.01B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 1341N
GlaxoSmithKline PLC
04 August 2017
Publication of Base Prospectus
The following base prospectus dated 3 August 2017 has been approved by the UK Listing Authority and is available for viewing:
GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GSK Capital K.K. GBP15,000,000,000 Euro Medium Term Note Programme
Copies of the base prospectus and the documents incorporated by reference within it have been submitted to the National Storage Mechanism and will shortly be available for inspection at and can be downloaded from:
www.morningstar.co.uk/uk/NSM
For further information, please contact:
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
Hot Features
Premium
UK Media enquiries: David Mawdsley (020) 8047 5564
Simon Steel (020) 8047 3763
European Analyst/Investor (020) 8047
enquiries: James Dodwell 2406
(020) 8047
Craig Haffey 6313
BASIS ON WHICH YOU MAY ACCESS THE BASE PROSPECTUS
Please note that the information contained in the base prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the base prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the base prospectus is not addressed. Prior to relying on the information contained in the base prospectus you must ascertain from the base prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirements.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PDIUGUUURUPMURC
(END) Dow Jones Newswires
August 04, 2017 04:06 ET (08:06 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
